RBC Cuts Insys Therapeutics (INSY) PT By 27%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- Wall St set for higher open as soft inflation data eases rate-hike fears
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil gains as stalled US-Iran talks trump supply recovery
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- HPE raises networking revenue outlook, secures $1.2B Vultr order
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Jefferies Cuts Price Target on Insys Therapeutics (INSY) Following Preliminary 1Q Subsys Revenues
April 12, 2016 7:57 AM EDTJefferies maintained a Buy rating on Insys Therapeutics (NASDAQ: INSY), and cut the price target to $17.00 (from $23.00), following the release of the company's preliminary estimated revenues from Subsys. INSY reported that Subsys Q1 revenues should be $61-62M vs consensus ($86M) forecasts. Many... More
INSYS Therapeutics' (INSY) Price Target Reduced to $28 at Piper Jaffray
April 11, 2016 1:36 PM EDTPiper Jaffray maintained an Overweight rating on INSYS Therapeutics (NASDAQ: INSY) and reduced its price target to $28.00 (from $46.00).
For an analyst ratings summary and ratings history on INSYS Therapeutics click here. For more ratings news on INSYS Therapeutics click here.
Shares of INSYS Therapeutics closed at $17.66 yesterday.
... MoreInsys Therapeutics (INSY) Offers Prelim. Q1 Subsys Revenue; Notes Drop in Volumes
April 11, 2016 6:51 AM EDTInsys Therapeutics, Inc. (Nasdaq: INSY) announced that its preliminary estimated revenues from Subsys® (fentanyl sublingual spray) for the first quarter of 2016 will be in the range of $61 million to $62 million. Estimated revenues for the quarter reflect a decline in demand, as Subsys... More
